Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes
Clinical trial NCT05553093 · RECRUITING
Trial details
- NCT number
- NCT05553093
- Sponsor
- Nanjing First Hospital, Nanjing Medical University
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-15
- Primary completion
- 2023-12-31
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.